dimethylarsinous glutathione
Small moleculeexperimental
Clinical trial activity
14 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2005 (NCT00509782)
Timeline
Indications
Studied for
- Bone Marrow Neoplasms · Phase 2
- Carcinoma, Hepatocellular · Phase 2
- Hematologic Neoplasms · Phase 2
- Leukemia, Myeloid, Acute · Phase 1
- Lymphoma · Phase 1
- Lymphoma, Non-Hodgkin · Phase 2
- Lymphoma, T-Cell, Peripheral · Phase 2
- Lymphoproliferative Disorders · Phase 1
- Multiple Myeloma · Phase 2
- Myelodysplastic Syndromes · Phase 1
- Myeloproliferative Disorders · Phase 1
- Neoplasms · Phase 1
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- clarinaparsin
- darinaparsin
- darinaparsin
- darinaparsin
- dimethylarsinous glutathione
- dmas(iii)g
- dmas(iii)sg
- s-(dimethylarsino)glutathione
- s-(dimethylarsino)-glutathione
- s-dimethylarsino-glutathione
- zio101
- zio 101
- zio-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02653976 | Phase 2 | Mar 1, 2016 | Solasia Pharma K.K. |
| NCT01689220 | Phase 1 | Sep 1, 2012 | Solasia Pharma K.K., Synex Consulting Korea Ltd. |
| NCT01435863 | Phase 1 | Sep 1, 2011 | Solasia Pharma K.K. |
| NCT01139346 | Phase 1 | Jun 1, 2010 | Ziopharm |
| NCT01139359 | Phase 1 | Jun 1, 2010 | Ziopharm |
| NCT00592163 | Phase 1 | Dec 1, 2007 | Ziopharm |
| NCT00591422 | Phase 1 | Aug 1, 2007 | Ziopharm |
| NCT00423306 | Phase 2 | Jan 1, 2007 | Ziopharm |
| NCT00423644 | Phase 2 | Jan 1, 2007 | Ziopharm |
| NCT00421213 | Phase 2 | Dec 1, 2006 | Ziopharm |
| NCT00303199 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2006 | Ziopharm |
| NCT00591396 | Phase 1 | Jul 1, 2005 | Ziopharm |
| NCT00592046 | Phase 1 | May 1, 2005 | Ziopharm |
| NCT00509782 | Phase 1 | May 1, 2005 | University of Texas at Houston, Ziopharm |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ziopharm | For profit | 11 | 10 | 2 | 2005 |
| Solasia Pharma K.K. | For profit | 3 | 3 | 2 | 2011 |
| Synex Consulting Korea Ltd. | For profit | 1 | 0 | 1 | 2012 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2005 |
4 organizations
Page 1 / 1